abstract: Galectin-1 (gal-1), a member of the mammalian b-galactoside-binding proteins, exerts biological effects by recognition of glycan ligands, including those involved in cell adhesion and growth regulation. In a previous study, we demonstrated that gal-1 induces cell differentiation processes on the membrane of choriocarcinoma cells BeWo, including the receptor tyrosine kinases, REarranged during transfection, janus kinase 2 and vascular endothelial growth factor receptor 3. Within this study, we examined which mitogenactivated protein kinases (MAPK) and serine/threonine kinases were phoshorylated by gal-1. Out of a number of 21 different MAPKs and other serine/threonine kinases, the stimulation of BeWo cells with gal-1 showed a significant alteration of signal intensity in extracellular-regulated kinases 1/2 (ERK1/2), Akt-3, Akt-pan and glycogen synthase kinase-a/b (GSK-3a/b). We demonstrated that gal-1 significantly inhibited ERK1/2, Akt-3/pan and GSK-3a/b phosphorylation in BeWo cells and in addition induced Elk1 transcription factor activation. In contrast to gal-1 effects, MAPK inhibitor U0126 reduced syncytium formation of BeWo cells. The results of our data showed that phosphorylation of MAP kinases are involved in gal-1-induced signal transduction processes in BeWo cells. Additional results obtained with MAPK inhibitor U0126 close the gap between syncytium formation induced by gal-1 and MAPK activation in trophoblast cells. Furthermore, we demonstrated that gal-1 induces the activation of Elk1, a transcription factor that is activated by MAPK pathways.
Introduction
Galectins, a growing family of carbohydrate-binding proteins, are defined by an affinity for b-galactosides (Barondes et al., 1994) . Although LacNAc (N-acetyl-lactosamine) is the basic ligand recognized by galectin-1(gal-1), the prototype galectin binds with increased avidity to multiple Galb1-4GlcNAc sequences presented on branched N-linked or on repeating LacNAc residues on N-and O-linked glycans.
Extracellular gal-1 exerts biological effects by the recognition of glycan ligands, including those involved in cell adhesion (Hughes, 2001) , metastasis (Raz and Lotan, 1987) , cell growth regulation (Wells and Mallucci, 1991; Adams et al., 1996) and apoptosis (Perillo et al., 1995) . Expression of gal-1 has been well documented in placental trophoblast cells, decidual cells (Vicovac et al., 1998) and in immune-privileged organs (Rabinovich, 1999) . Furthermore, there is evidence of a role for gal-1 in promoting murine fetomaternal tolerance in allogenic matings, suggesting a potential approach for therapeutic intervention aimed at restoring immune cell homeostasis in failing pregnancies (Blois et al., 2007) . In addition, it has been demonstrated that gal-1 induces cell differentiation processes in syncyciotrophoblast and extravillous trophoblast layer. It has also been shown that gal-1 binds to BeWo cells, which form a syncytium in vitro, but does not bind to freshly isolated trophoblast cells and to chorioncarcinoma cells Jeg-3, which cannot form a syncytium (Jeschke et al., 2004) .
Multiple signalling pathways in trophoblast cells have been elucidated in the last years, including the members of the mitogen-activated protein family (MAPK) (Kita et al., 2003; Daoud et al., 2005) and the janus kinase 2 (JAK2) and signal transducer and activator of transcription cytokine signal transducing pathway (STAT) (Busch et al., 2009) [through which several cytokines, including leukaemia-inhibitory factor, hepatocyte growth factor, interleukin (IL-6), IL-11 and granulocyte-macrophage -colony-stimulating factor, are known to signal] (Fitzgerald et al., 2005 (Fitzgerald et al., , 2008 . As tyrosine phosphorylation is a major mechanism that controls multiple biological processes including cell differentiation, survival and proliferation (Hunter, 1998) , we demonstrated, in a recent study, that gal-1 induced a significant alteration of signal intensity in 3 from 71 different receptor tyrosine kinases (RTKs) on BeWo cells, the REarranged during transfection (RET), the JAK2 and the vascular endothelial growth factor receptor 3 (VEGFR3), showing specificity of gal-1 binding to cell surface glycoproteins at the concentration used for this experiment (Fischer et al., 2009) .
To better understand the signal transduction processes that are influenced by gal-1 in trophoblast cells, the aim of this study was to examine which MAPKs and serine/threonine kinases were phoshorylated in choriocarcinoma cells BeWo by the lectin. To demonstrate the effect of MAPK and gal-1 on the syncytium formation in trophoblast cells, choriocarcinoma cell cultures BeWo, derived from human gestational choriocarcinoma and permanently established in 1968 by Pattillo et al. , offer an attractive model. BeWo cells reveal two coexisting phenotypes: the cytotrophoblast-like and the syncytiotrophoblast-like phenotype (Pattillo et al., 1968) .
Materials and Methods

Cells
The choriocarcinoma cell line BeWo was obtained from the European Collection of Cell Cultures (ECACC, UK). Cells were cultured in DMEM medium (Dulbecco's Modified Eagle Medium, Biochrom, Germany) supplemented with 10% heat-inactivated fetal calf serum without antibiotics and antimycotics, 3.7 g/l NaHCO 3 , 4.5 g/l D-glucose, 1.028 g/l stable glutamine and Na-pyruvate.
Human phospho-MAPK array
BeWo cells (4 × 10 6 cells in 15 ml supplemented DMEM medium) were incubated in 175 ml cell culture bottles for 24 h in the absence (controls) and presence of 60 mg/ml gal-1 (recombinant human gal-1, Sigma, Missouri, USA). Human Phospho-MAPK Array (R&D Systems, Minneapolis, MN, USA) was used to simultaneously detect the relative levels of phosphorylation of nine MAPKs and nine other serine/threonine kinases.
Cells were rinsed with PBS (phosphate-buffered saline), covered with lysis buffer, rocked (2-88C, 30 min) and centrifuged (room temperature, 14 000g, 5 min). The Bradford protein assay (Bio-Rad Laboratories, UK) was used to determine protein concentration. A total amount of 200 mg protein was applied to each membrane. To block the membranes, 2 ml of array buffer was added into each well for 1 h. Afterwards, lysate and array buffer were mixed and added on each well overnight at 68C. Each array was placed into an individual container and washed with wash buffer. Afterwards, the detection antibody cocktail concentrate was diluted with an array buffer. Then the arrays were returned to the 4-well multi-dish and were incubated for 2 h at room temperature. Afterwards, each array was washed as previously mentioned. The streptavidin-horse-radish peroxidise (HRP) was diluted in an array buffer. The arrays were returned to the 4-well multi-dish and were incubated for 30 min at room temperature. After washing, the signal was detected directly from the membranes using chemoluminescence imaging system. The array layout is shown in Table I . The signal intensities from 10 sets of duplicate membranes obtained from three independent experiments were compared and quantified with the Quantity One Version 4.5.2 program. Positive and negative controls were used to normalize the results from different membranes being compared.
The SPSS/PC software package, version 15.01 (SPSS, Germany), was used for collection, processing and statistical data analysis. Statistical analysis was performed using the non-parametric Wilcoxon's signed rank tests for comparison of the means. P , 0.05 values were considered statistically significant.
TransAM
TM Elk1 transcription factor assay BeWo cells (4 × 10 6 cells in 15 ml supplemented DMEM medium) were incubated in 75 ml cell culture bottles for 24 h in the absence (controls) and presence of 60 mg/ml gal-1 (Sigma). All experiments were performed twice in triplicates. The TransAM TM Elk1 transcription factor assay kit (Active Motif, Rixensart, Belgium) contains a 96-well plate to which an oligonucleotide containing the consensus-binding site for Elk1 has been immobilized. The activated Elk1 contained in nuclear extracts specifically binds to this oligonucleotide. By using an antibody that is directed against phosphorylated Elk1, the complex bound to the oligonucleotide is detected. Addition of a secondary HRP-conjugated antibody provides a sensitive colorimetric readout that is easily quantified by spectrophotometry.
At first, the nuclear extract was prepared. The Bradford protein assay (Bio-Rad Laboratories) was used to determine protein concentration. A total amount of 500 mg protein was used for the experiments. Afterwards, the samples and positive controls were diluted. To complete, the binding buffer was added. For a competitive binding experiment, a binding buffer that contains wild-type or mutated consensus oligonucleotide was added. The plate was covered with an adhesive cover and incubated for 1 h at room temperature. After washing and adding 100 ml of diluted Elk1 antibody, the plate was incubated again for 1 h at room temperature. After washing and the addition of HRP-conjugated antibody, the plate was incubated again for 1 h at room temperature. In the final steps, developing solution was added and incubated for 5 min at room temperature and protected from direct light. Afterwards, stop solution was added. The absorbance was read on a spectrophotometer within 5 min at 450 nm with a reference wavelength of 655 nm.
Statistical analysis was performed as mentioned in section 'Human phospho-MAPK array'.
Incubation of BeWo cells with MAPK-inhibitor
BeWo cells (4 × 10 6 cells in 15 ml supplemented DMEM medium) were incubated for 24 and 48 h in chamber slides with 1, 3 and 10 mM MAPK-inhibitor U0126 (Promega, Mannheim, Germany), which completely blocks extracellular-regulated kinases 1/2 (ERK1/2) phosphorylation. Untreated cell cultures were used as controls. All experiments were repeated six times.
Analysis of syncytium formation in BeWo cells after MAK-inhibitor treatment by E-cadherin, b-catenin and syncytin staining
Slides were fixed with ethanol/methanol (1/1) for 15 min, washed with PBS (pH 7.4, 5 min) and incubated with Ultra V Block (Labvision, USA, 15 min, room temperature). Then, the slides were incubated with the primary antibody overnight at 48C (Table II) . After washing, chamberslides were incubated with Cy3 labelled Goat-anti-Mouse antibody or Donkey anti-Goat immunoglobulin G (IgG; room temperature, 30 min), which will appear red, or with Cy2 labelled goat-anti-rabbit IgG (room temperature, 45 min), which will appear green. The slides were finally embedded in mounting buffer containing (DAPI, Denmark) and examined with a photomicroscope (Zeiss Axiophot, Germany). Images were obtained with a digital camera system (Axiocam, Zeiss, Germany). The intensity of the antigen expression was evaluated by the examination of the percentage of membranes staining positive compared with the cell number (100% ¼ all membranes are positive, 0% ¼ no membrane is positive). Statistical analysis was performed as mentioned in section 'Human phospho-MAPK array'.
Analysis of E-cadherin and b-catenin expression on blots
BeWo cells were separately grown on a sterile 6-well chamber slide at a density of 80 000 cells/ml DMEM medium. After 24 h, the medium was changed and the cells were incubated with 60 mg/ml gal-1 (Sigma) for 24 h. The remaining medium was removed after incubation and the wells were washed with PBS. Next, 1 ml of lysis buffer containing protease inhibitor cocktail and RIPA buffer (both Sigma), in a dilution of 1:100, was applied on each well. Incubation with RIPA buffer for 15 min on ice followed. Finally, the lysate was removed from the wells and frozen at 2208C. Total protein concentration was subsequently determined via Bradford Assay. A protein amount of 10 000 ng was used for western blotting. The lysate proteins were first separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and then transferred onto a polyvinylidene fluoride membrane (Millipore, Billerica, USA). Between each step, the membrane was washed in casein solution from the Vectastain w ABC-AmP TM mouse-IgG-kit for western blot detection (Vector Laboratories, Burlingame, USA). If not otherwise stated, the experiments were carried out at room temperature. The membrane was first blocked in casein solution (diluted 1:10 in distilled water) for 1 h. Next, the membrane was incubated with primary antibody for 16 h at 48C (Table II) . The biotinylated anti-mouse IgG secondary antibody from the Vectastain w ABC-AmP TM mouse-IgG-kit (Vector Laboratories) was diluted in casein solution to a final concentration of 1.5 mg/ml and incubated with the membrane for 45 min. Afterwards, the membrane was incubated with the Vectastain ABC-AmP Reagent (Vector Laboratories) for 20 min. The membrane was then treated with 0.1 M Tris buffer with a pH of 9.5 for 5 min. The blots were developed with the S-bromo-Dchloro-3-indolyl phosphate/nitro blue tetrazolium-chromogen-substrate solution. After 3 min of staining, the reaction was stopped with distilled water and the membrane kept dry. The experiments were repeated four times.
Western blots were detected with the BioRad Universal Hood II (BioRad Laboratories, Segrate, Milan, Italy) and quantified using the BioRad Quantitiy One Software (BioRad Laboratories, Hercules, USA).
Quantification of b-catenin with ELISA
For the quantification of b-catenin in cell lysates, the Surveyor IC Immunoassay (R&D Systems, Abingdon, UK) was used as a two-site sandwich ELISA. In brief, an antibody specific for b-catenin has been pre-coated onto a microplate. Standards and samples are added and any b-catenin present is bound by the immobilized antibody. After washing away unbound material a biotinylated detection antibody recognizing b-catenin is used for detection, utilizing a standard streptavidin-HRP format. Substrate solution is added to the wells and colour develops in proportion to the amount of b-catenin bound in the initial step. The colour development is stopped and the intensity of the colour is measured. Galectin-1 and trophoblast MAP kinases
Results
Human phospho-MAPK array
As demonstrated in Fig. 1 Figure 1 The effect of 60 mg/ml galectin-1 for 24 h on phosphorylation of ERK1/2, Akt3/pan and GSK-3a/b in BeWo cells. Signal intensity was determined by computerized analysis of chemiluminescence signal on the membranes. Incubation of BeWo cell cultures in vitro with 60 ml/ml gal-1 for 24 h significantly reduced the intensity of the ERK1 T202/Y204 signal to 36.53% (P ¼ 0.028, SEM ¼ 14.043), the intensity of the ERK2 T185/Y187 signal to 41.14% (P ¼ 0.043, SEM ¼ 9.228), the intensity of the GSK-3a/b S21/S9 signal to 78.76% (P ¼ 0.043, SEM ¼ 2.609), the intensity of the Akt-3
S472
Kinase signal to 73.67% (P ¼ 0.043, SEM ¼ 7.085) and the intensity of the Akt-pan S473,S474,S472 Kinase signal to 65.81% (P ¼ 0.043, SEM ¼ 16.412), compared with non-treated control cultures (¼100%). Data shown represent means + SEM.
inhibit Elk1-binding to the ELISA plate by a factor of 2.44. Although wild-type oligonucleotide was used, stimulation of the BeWo cells with 60 ml/ml gal-1 up-regulated Elk1-binding by a factor of 1.45. In summary, gal-1 induced higher specific Elk1-DNA-binding in the range of 122 -145%.
Analysis of syncytium formation in BeWo cells after MAPK-inhibitor treatment by E-cadherin, b-catenin and syncytin staining
Since, in previous studies, gal-1 had suppressive effects on ERK1/2 phosphorylation in BeWo cells and, simultaneously, increasing effects on syncytium formation, we analysed the effects of a complete block of ERK1/2 phosphorylation by inhibition of MAPK through the specific inhibitor U0126. In contrast to these gal-1-induced effects, we observed, in six independent experiments, U0126 dose-dependent reduction of indicators for syncytium formation. Application of the highest used concentration of 10 mM U0126 induced a 72% reduction of syncytin compared with untreated controls (Figs 3A and B; 4) , while E-cadherin and b-catenin are increased by 275% (Figs 3C and D; 4) and 216% (Figs 3E and F; 4) , respectively (for all P , 0.05, Wilcoxon's signed ranks test). The gal-1 expression in treated BeWo was not significantly affected by U0126 (Figs 3G and H; 4) . A summary of the results is presented in Fig. 4 .
Analysis of E-cadherin and b-catenin expression on blots
Western blot detection of E-cadherin and b-catenin expression of BeWo cell lysates is shown in Fig. 5A . E-Cadherin generates a main protein band in the molecular mass range of 120 kDa and b-catenin at 100 kDa. The left lane, which represents protein expression of control BeWo cells, is stained more intensely than the right lane for E-cadherin and b-catenin. The right lane represents BeWo cells that were incubated with 60 mg/ml gal-1. Applying BioRad Quantitiy One Software (BioRad Laboratories), a significant decrease in E-cadherin (82%, P ¼ 0.028) and b-catenin (64.6%, P ¼ 0.03) expression of BeWo cells could be quantified. Staining intensity of E-cadherin and b-catenin expression in unstimulated (control) and stimulated BeWo cells in mm 2 volume was normalized to b-actin staining intensity, respectively.
Quantification of b-catenin with ELISA
In addition to western blot detection of b-catenin expression, we quantified membrane-bound b-catenin with an ELISA. Mean expression of b-catenin in unstimulated BeWo cells was 107.5 ng/ml. Gal-1 induced downregulation of membrane-bound b-catenin to mean values of 16.8 ng/ml. Differences in control and gal-1-treated BeWo cells were significant ( Fig. 5B , P ¼ 0.008).
Discussion
Galectins are members of a family of soluble animal lectins defined by an affinity for b-galactosides (Hirabayashi and Kasai, 1984) . These human proteins have been shown to be involved in cell-matrix adhesion, resistance to apoptosis and angiogenesis. In addition, the involvements of galectins in cellular processes that are crucial for cancer progression and metastasis have been reported (Rabinovich et al., 2002 ; van den Brule et al., 2003) . It has already been demonstrated that gal-1 is expressed by syncytiotrophoblasts in term and first trimester placenta (Walzel et al., 1995; Vicovac et al., 1998) and binds to BeWo cells, which can form a syncytium. In a recent study, we have shown that gal-1 stimulates the syncytium formation, accompanied by increased syncytin expression, in choriocarcinoma cells BeWo and human villous trophoblasts cells in vitro and inhibits the expression of b-catenin and E-cadherin, which are indicators for cell fusion (Coutifaris et al., 1991; Getsios et al., 2000) and also inhibits the proliferation marker Ki67 (Zabaglo et al., 2003; Fischer et al., 2010) . Therefore, we suggested that gal-1 may be a major trigger for the process of trophoblast cell fusion. The transmission of extracellular signals into intracellular responses is a complex process that often involves the activity of MAPKs. Two upstream protein kinases activated in series lead to activation of a MAP kinase: a MAPK kinase (MEKK or MAPKKK or MAPK3) activates a MAP/ERK kinase (MEK or MAPKK or MAP2K) that stimulates a phosphorylation-dependent increase in the activity of the MAP kinase (ERK) (Pearson et al., 2001) . MEK1 and MEK2 have been shown to fully activate ERK1/2 in vitro (Robinson et al., 1996) . It has previously been demonstrated that gal-1 can modulate critical immunoregulatory molecules and their associated functions through a nonapoptotic ERK1/2 pathway, showing an essential role for gal-1 in the regulation of monocyte and macrophage physiology (Barrionuevo et al., 2007) . Furthermore, Fuertes et al. demonstrated that T-cell activation leads to gal-1 expression and that this up-regulated expression involves signalling through MEK1/ERK (Fuertes et al., 2004) . In addition, they showed that up-regulated expression of gal-3 in Phorbol-12-myristate-13-acetate-stimulated macrophages involves signalling through the Ras/MAPK pathway, suggesting a common signalling pathway for gal-1 and gal-3 gene expression under pro-or anti-inflammatory conditions (Kim et al., 2003) . In this study, we now demonstrate that gal-1 reduces the relative phosphorylation of ERK1 on phosphotyrosine residue T202/Y204 to 36.53% ( Fig. 1) and ERK2
T185/Y187 to 41.14% ( Fig. 1 ) in choriocarcinoma cells
BeWo. ERK1 and ERK2 show a nearly 85% identity (Boulton et al., 1991) and are stimulated to some extent by a vast number of ligands (Lewis et al., 1998) . Perhaps, the most well-defined signalling pathway from the cell membrane to ERK1/2 is used by the RTKs. Stimulation of these receptors by the appropriate ligand results in an increase in receptor catalytic activity and subsequent autophosphorylation on tyrosine residues (Pearson et al., 2001) . We have previously demonstrated that the concentration of 60 mg/ml gal-1 significantly reduced phosphorylation of the RTK RET, which could modify the MEK1/2/ERK1/2 pathway via the JAK2, implicating the STAT3 (Fischer et al., 2009) . In our hands, we could show that blocking of MAPK/MEK with the inhibitor U0126 leads to inhibition of syncytium formation in BeWo cells. Syncytium formation was investigated by analysing expression of syncytin, E-cadherin and b-catenin as described previously (Fischer et al., 2010) . Gross et al. have shown that Akt/glycogen synthase kinase-3b (GSK-3b)-and JAK2/STAT3 signalling pathways are linked processes: they suggested that opioid-induced cardioprotection occurs via the phosphorylation of JAK2 and STAT3, which, in turn, regulates heterodimeric phosphoinositol 3-kinase (PI3K)-dependent proteins Akt and GSK-3b (Gross et al., 2006) . In this study, we show that gal-1 inhibits the phosphorylation of Akt-3/pan and GSK-3a/b in choriocarcinoma cells BeWo as demonstrated in Fig. 1 . Incubation of BeWo cell cultures with 60 ml/ml gal-1 significantly reduce the intensity of phosphorylated GSK-3a/b S21/S9 to 78.76%, of phosphorylated Akt-3 S472 to 73.67% and of phosphorylated Akt-pan S473,S474,S472 to 65.81% compared with non-treated control cultures. Three genes have been identified encoding for the isoforms of the serine/threonine protein kinase B family, or Akt in mammals. Members of this family, Akt-1, Akt-2 and Akt-3, share 80% homology. Akt is a signalling component of the tyrosine kinase growth factor receptors and G-coupled receptors. These receptors engage the PI3K, which phosphorylates phosphatidylinositol-4,5-bisphosphate to convert PIP2 to PIP3. Then PIP3 recruits other signalling components such as Akt and PDK. PDK then phosphorylates and activates Akt (Vanhaesebroeck and Alessi, 2000) . Accumulating evidence shows a central role of Akt in tumour development and response to cancer treatment (Wendel et al., 2004) . It has been shown that gal-1 shifts After 24 h, the expression of different molecules was assessed. Error bars indicate standard error (n ¼ 6 independent experiments), *P , 0.05 compared with control (Wilcoxon's signed rank test).
Galectin-1 and trophoblast MAP kinases the interaction of the activated molecule away from PI3K and toward Raf-1 which functions in the MAPK/ERK signal transduction pathway as part of a protein kinase cascade, at the same time that it augments and prolongs Ras activation (Elad-Sfadia et al., 2002) . Furthermore, it has been demonstrated that both the PIK3-Akt-mammalian target of rapamycin-hypoxia-inducible factor-1a and ERK-HIF-1a signalling pathways are crucial for increasing VEGF expression in response to hypoxia in BeWo cells (Fujita et al., 2010) . In addition, it has been suggested that in the MEK1/2/ERK1/2 and PI3K/Akt-1 pathways differentially mediate VEGF-stimulated human placental artery endothelial cell proliferation (Wang et al., 2009) . Interestingly, we have previously shown that gal-1 stimulates VEGFR3 phosphorylation in BeWo cells (Fischer et al., 2009) .
In addition, gal-1 prolongs the epidermal-growth-factor (EGF)-induced response (Elad-Sfadia et al., 2002) in non-human COS-7 cells [cells being CV-1 (simian) in Origin, and carrying the SV40 genetic material]. In trophoblast cells, EGF phosphorylates GSK-3b and stimulates b-catenin gene expression (LaMarca et al., 2008) . Surprisingly, we could not detect a phosphorylation and therefore activation of the EGF receptor pathway in BeWo cells after stimulation with gal-1 (Fischer et al., 2009) . GSK-3 is a serine/threonine protein kinase and is encoded by two known genes GSK-3a and b in mammals (Frame and Cohen, 2001) . Most recently, it has been shown to regulate trophoblast cell survival and invasive differentiation in trophoblast cells (Dash et al., 2005) . In the absence of external stimuli, GSK-3b phosphorylates b-catenin, which retains the b-catenin within the cytoplasm where it undergoes degradation (Kimelman and Xu, 2006) . In a recent study, we showed that gal-1 inhibits the expression of b-catenin (Fischer et al., 2010) , which acts as an indicator for cell fusion (Getsios et al., 2000) . GSK-3b is usually found in active (dephosphorylated) and inactive (phosphorylated) state. Therefore results obtained with this study favour the b-catenin degradation pathway. In addition, Akt increases the activity of glycogen synthase by phosphorylating and inactivating GSK-3b (Esquiliano et al., 2009) . Activation of GSK-3b could induce higher binding of transcription factors to its specific response elements. The E-twenty six-domain transcription factor Elk1 plays a pivotal role in transducing extracellular signals into a transcriptional response by acting as a target of the MAP kinase signalling pathway (Sharrocks, 2002; Shaw and Saxton, 2003) . Each of the three MAPK modules, ERK, c-Jun Nterminal kinase (JNK) and p38 MAPK, can participate in the activation of Elk1 (Brunet and Pouyssegur, 1997; Lewis et al., 1998) , and Peters et al. demonstrated the utilization of the MAPK pathway by EGF and fibroblast growth factor-2 in trophoblast cells by growth factor stimulation of a Gal4-DNA-binding/Elk1 transactivational domain fusion construct, using the Rcho-1 trophoblast cell line as a model (Peters et al., 2000) . However, the role of Elk1 in the placenta is poorly understood. In a recent study, it could be demonstrated that the protein Depp, which is induced by progesterone in human endometrial stromal cells, activates Elk1. As previous studies have shown that gal-1 decreases cellular hCG and progesterone production as well as hCG b gene transcription (Jeschke et al., 2004) , gal-1 and Elk1 could have linked activities in the placenta. This is in line with the results of our study, because we demonstrated that the stimulation of BeWo cells with gal-1 showed a higher relative activation of Elk1 (Fig. 2) .
Conclusion
We have shown in this study that gal-1 inhibits phosphorylation of ERK1 on residue T202/Y204, ERK2 on T185/Y187, Akt-3 on Serin 472, Akt-pan on S473,S474,S472, GSK-3a/b on S21/S9 and upregulates Elk1 signals in choriocarcinoma cells BeWo (see Fig. 6 ). Inhibition of MAPK pathway leads to inhibition of syncytium formation in trophoblast cells BeWo.
